Suppr超能文献

[伴TP53突变的惰性白血病性非淋巴结套细胞淋巴瘤误诊为慢性淋巴细胞白血病:1例报告及文献复习]

[Indolent leukemic non-nodal mantle cell lymphoma with TP53 mutation misdiagnosed as chronic lymphocytic leukemia: a case report and literature review].

作者信息

Qiu T L, Zhang Y P, Wang Y, Wu Y J, Shi W Y, Xia Y

机构信息

Department of Hematology, Lymphoma Center, Key Laboratory of Nanjing Medical University, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing 210029, China.

Department of Hematology of Affiliated Hospital of Nantong University, Nantong 226001, China.

出版信息

Zhonghua Xue Ye Xue Za Zhi. 2025 Feb 14;46(2):174-178. doi: 10.3760/cma.j.cn121090-20241205-00538.

Abstract

Patients with leukemic non-nodal mantle cell lymphoma (nnMCL) typically exhibit an indolent clinical course, and when asymptomatic and without treatment indications, a watchful observation follow-up can be adopted. This article presents a retrospective summary of a case of nnMCL, misdiagnosed as chronic lymphocytic leukemia (CLL) and carrying a TP53 mutation, along with a literature review. The case highlights the importance of differential diagnosis between nnMCL and CLL, and suggests that for nnMCL patients, the presence of high-risk biological markers such as TP53 mutations does not necessarily indicate an immediate need for treatment; rather, a strict watch-and-wait strategy may be a more appropriate option.

摘要

白血病性非结节性套细胞淋巴瘤(nnMCL)患者通常表现出惰性临床病程,无症状且无治疗指征时,可采用密切观察随访。本文回顾性总结了1例误诊为慢性淋巴细胞白血病(CLL)且携带TP53突变的nnMCL病例,并进行文献复习。该病例突出了nnMCL与CLL鉴别诊断的重要性,提示对于nnMCL患者,存在TP53突变等高风险生物学标志物不一定意味着立即需要治疗;相反,严格的观察等待策略可能是更合适的选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b118/11951215/b70a7992d1a9/cjh-46-02-174-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验